Ligand Pharmaceuticals Inc (LGNZZ) SEC Filings — 2024

Filings

• Ligand Pharmaceuticals Inc SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Ligand Pharmaceuticals Q3 2024 Update — 10-Q · Nov 8, 2024
• Ligand Pharmaceuticals Inc SC 13G/A Filing — SC 13G/A · Nov 8, 2024
• Ligand Pharmaceuticals Files 8-K on Financials — 8-K · Nov 7, 2024
• Ligand Pharmaceuticals Inc SC 13G/A Filing — SC 13G/A · Nov 1, 2024
• Ligand Pharmaceuticals Q2 2024 Update — 10-Q · Aug 7, 2024
• Ligand Pharmaceuticals Files 8-K on Financials — 8-K · Aug 6, 2024
• Ligand Pharmaceuticals Appoints New Chief Medical Officer — 8-K · Aug 2, 2024
• Ligand Pharmaceuticals Completes Asset Acquisition — 8-K · Jul 17, 2024
• Ligand Pharmaceuticals Enters New Loan Agreement — 8-K · Jul 10, 2024
• Ligand Pharmaceuticals Announces Material Definitive Agreement — 8-K · Jul 8, 2024
• Ligand Pharmaceuticals Acquires Avista Therapeutics for $100M Upfront — 8-K · Jun 27, 2024
• Ligand Pharmaceuticals Appoints New CFO, Todd Simon — 8-K · Jun 18, 2024
• Ligand Pharma Moves HQ, Elects Directors — 8-K · Jun 17, 2024
• Ligand Pharma Files Proxy Materials — DEFA14A · Jun 3, 2024
• Thermo Fisher to Acquire Ligand Pharma for $7.2B — 8-K · May 30, 2024
• Ligand Pharma Files Proxy Supplement — DEFA14A · May 9, 2024
• Ligand Pharmaceuticals Inc. Files 10-Q for Q1 2024 — 10-Q · May 8, 2024
• Ligand Pharmaceuticals Enters Material Definitive Agreement — 8-K · May 7, 2024
• Ligand Pharmaceuticals Inc. Files Definitive Proxy Statement — DEF 14A · Apr 25, 2024
• Ligand Pharmaceuticals Relocates Executive Offices — 8-K · Apr 19, 2024
• Ligand Pharmaceuticals Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 29, 2024
• Ligand Pharma Files 8-K on Financial Results and Operations — 8-K · Feb 27, 2024
• Ligand Pharmaceuticals Inc SC 13G Filing — SC 13G · Feb 14, 2024
• Janus Henderson Amends Ligand Pharma Stake Filing — SC 13G/A · Feb 13, 2024
• Vanguard Group Amends Ligand Pharma Stake to 12.8% — SC 13G/A · Feb 13, 2024
• Goldman Sachs Discloses Passive Stake in Ligand Pharma — SC 13G · Feb 12, 2024
• BlackRock Trims Ligand Pharma Stake to 6.1% — SC 13G/A · Jan 22, 2024
• Ligand Pharma Files Routine 8-K on Jan 5, No Major News — 8-K · Jan 8, 2024